Cargando…

The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

Detalles Bibliográficos
Autores principales: Liang, Weifeng, Gu, Ming, Zhu, Lingxiang, Yan, Ziqi, Schenten, Dominik, Herrick, Shelby, Li, Hongmin, Samrat, Subodh Kumar, Zhu, Jiapeng, Chen, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098221/
https://www.ncbi.nlm.nih.gov/pubmed/37055405
http://dx.doi.org/10.1038/s41392-023-01418-3
_version_ 1785024757790408704
author Liang, Weifeng
Gu, Ming
Zhu, Lingxiang
Yan, Ziqi
Schenten, Dominik
Herrick, Shelby
Li, Hongmin
Samrat, Subodh Kumar
Zhu, Jiapeng
Chen, Yin
author_facet Liang, Weifeng
Gu, Ming
Zhu, Lingxiang
Yan, Ziqi
Schenten, Dominik
Herrick, Shelby
Li, Hongmin
Samrat, Subodh Kumar
Zhu, Jiapeng
Chen, Yin
author_sort Liang, Weifeng
collection PubMed
description
format Online
Article
Text
id pubmed-10098221
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100982212023-04-14 The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression Liang, Weifeng Gu, Ming Zhu, Lingxiang Yan, Ziqi Schenten, Dominik Herrick, Shelby Li, Hongmin Samrat, Subodh Kumar Zhu, Jiapeng Chen, Yin Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-04-13 /pmc/articles/PMC10098221/ /pubmed/37055405 http://dx.doi.org/10.1038/s41392-023-01418-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Liang, Weifeng
Gu, Ming
Zhu, Lingxiang
Yan, Ziqi
Schenten, Dominik
Herrick, Shelby
Li, Hongmin
Samrat, Subodh Kumar
Zhu, Jiapeng
Chen, Yin
The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
title The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
title_full The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
title_fullStr The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
title_full_unstemmed The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
title_short The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression
title_sort main protease of sars-cov-2 downregulates innate immunity via a translational repression
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098221/
https://www.ncbi.nlm.nih.gov/pubmed/37055405
http://dx.doi.org/10.1038/s41392-023-01418-3
work_keys_str_mv AT liangweifeng themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT guming themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT zhulingxiang themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT yanziqi themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT schentendominik themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT herrickshelby themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT lihongmin themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT samratsubodhkumar themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT zhujiapeng themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT chenyin themainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT liangweifeng mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT guming mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT zhulingxiang mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT yanziqi mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT schentendominik mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT herrickshelby mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT lihongmin mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT samratsubodhkumar mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT zhujiapeng mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression
AT chenyin mainproteaseofsarscov2downregulatesinnateimmunityviaatranslationalrepression